🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Apple, Nvidia and Pfizer fall premarket; Lululemon rises

Published 16/10/2023, 13:12
© Reuters
AAPL
-
NVDA
-
DHI
-
PFE
-
RDY
-
LULU
-
NVO
-

Investing.com -- U.S. futures edged higher Monday, at the start of a week that sees the quarterly earnings season ramp up.

Here are some of the biggest premarket U.S. stock movers today:

  • Rite Aid (NYSE:RAD) stock rose 4.5%, rebounding after Friday’s 17% drop, after the drugstore chain filed for Chapter 11 bankruptcy and announced it has received a commitment for $3.45 billion in new financing from some of its lenders.

  • Apple (NASDAQ:AAPL) stock fell 0.8% after Bloomberg reported the tech giant’s new iPhone 15 is facing challenges in the Chinese market, with sales lagging behind its predecessor - the iPhone 14.

  • Nvidia (NASDAQ:NVDA) stock fell 1% following a Bloomberg News report that the U.S. will strengthen restrictions on China's access to advanced chip technology.

  • Pfizer (NYSE:PFE) stock fell 2.6%, while German partner BioNTech (NASDAQ:BNTX) stock dropped 5.4% and rival Moderna (NASDAQ:MRNA) fell 4%, after the U.S. drugmaker slashed the sales forecast for its COVID vaccine and therapy last week.

  • Manchester United (NYSE:MANU) stock fell 11% after reports that British billionaire Jim Ratcliffe is looking to acquire only a 25% stake in the soccer club, raising concerns that a buyout by Qatar's Sheikh Jassim bin Hamad al Thani could be off the table.

  • Novo Nordisk (NYSE:NVO) stock rose 0.1% after the drugmaker agreed to buy a hypertension drug from KBP Biosciences for up to $1.3 billion.

  • Lululemon (NASDAQ:LULU) stock rose 6.3% with the athleticwear company set to join the benchmark S&P 500 index on Wednesday, S&P Dow Jones Indices confirmed last week.

  • DR Horton (NYSE:DHI) stock rose 2% after Goldman Sachs upgraded its stance on the housebuilder to ‘buy’ from ‘neutral’, while KB Home (NYSE:KBH) stock fell 2.1% as Goldman cut to ‘neutral’ from ‘buy’.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2024 - Fusion Media Limited. All Rights Reserved.